NHS Greater Glasgow and Clyde
nhsggc.org.ukLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
217
Active
29
Phase 3
9
Total enrollment
161,204
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Norepinephrine | — | — | — | — | — | 1 | |
| NanO2TM | — | — | — | — | — | 1 | |
| Ixekizumab | — | — | — | — | — | 2 | |
| Secukinumab | — | — | — | — | — | 1 | |
| Bimekizumab | — | — | — | — | — | 1 | |
| Tirzepatide | — | — | — | — | — | 1 | |
| Anifrolumab | — | — | — | — | — | 1 |
Next readouts
- 2025-03-17
- 2026-07-31
- 2026-11
- 2027-02-28
- 2028-02
Top conditions
- Heart Failure14
- Stroke13
- Cardiovascular Diseases10
- Obesity6
- Rheumatoid Arthritis6
- Crohn Disease5
- Insomnia5
- Spinal Cord Injuries5
Frequently asked questions about NHS Greater Glasgow and Clyde
- How many clinical trials does NHS Greater Glasgow and Clyde have on ClinicalTrials.gov?
- NHS Greater Glasgow and Clyde is listed as the lead sponsor on 217 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
- How many of NHS Greater Glasgow and Clyde's trials are in Phase 3?
- 9 of NHS Greater Glasgow and Clyde's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does NHS Greater Glasgow and Clyde focus on?
- NHS Greater Glasgow and Clyde's most-studied conditions on ClinicalTrials.gov are Heart Failure, Stroke, Cardiovascular Diseases, Obesity, Rheumatoid Arthritis.
- When are NHS Greater Glasgow and Clyde's next clinical trial readouts?
- NHS Greater Glasgow and Clyde has 5 upcoming primary-completion readouts tracked here; the soonest is “Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue”, expected around 2025-03-17.